NYC-Miami Myeloma MRD 2020

VJHemOnc is an official media partner of the NYC-Miami Myeloma MRD 2020 Virtual Meeting, organized by the MMRF & Memorial Sloan Kettering Cancer Center, taking place on the 8th of October 2020.

This meeting will bring together leading experts in multiple myeloma who will discuss the use of measurable residual disease (MRD) in clinical and trial settings, furthering our understanding of recent advances in the disease, and encouraging interactive discussion.

Explore the exciting program below and don’t forget to register your place before the 8th of October!


Thursday 8th October 2020 (All times are EST)

09:00 – 9:10 AM
Welcome and Introductions

09:10 – 9:30 AM
MRD in 2020: BMCTN consensus document
Luciano Costa, MD, University of Alabama at Birmingham

9:30 – 9:50 AM
Benjamin Derman, MD, University of Chicago

9:50 – 10:10 AM
New MRD technologies and future regulatory paths
Dickran Kazandjian, MD, NCI and FDA


Session 1: Should sustained MRD negativity be used to stop the treatment?
10:10 – 10:20 AM
YES: Nina Shah, UCSF and MMRC Steering Committee
10:20 – 10:30 AM
NO: Ajai Chari, MD, Icahn School of Medicine at Mount Sinai and MMRC Steering Committee
Session 2: Should MRD+ be used to re-initiate the treatment?
10:30 – 10:40 AM
YES: Elisabet Manasanch, MD Anderson
10:40 – 10:50 AM
NO: Amrita Krishnan, MD, City of Hope and MMRC Steering Committee

Session 3: Should MRD be used to guide delayed ASCT?
10:40 – 10:50 AM
Continue with transplant: Noa Biran, MD, John Theurer Cancer Center
10:30 – 11:00 AM
Hold off transplant: Paul Richardson, MD, DFCI


11:00 – 11:25 AM

MRD future directions
Moderator: Daniel Auclair, PhD, MMRF

  • Ola Landgren, MD, PhD
  • Dickran Kazandjian, MD, NCI, FDA
  • Ajai Chari, MD, Icahn School of Medicine at Mount Sinai and MMRC Steering Committee
  • Suzanne Lentzsch, MD, PhD, Columbia University Irving Medical Center
  • James Hoffman, University of Miami/Sylvester Comprehensive Cancer Center
  • Sundar Jagannath, MD, Mount Sinai
  • Noa Biran, MD, John Theurer Cancer Center


Summary and Adjournment
11:25 – 11:30 AM
C. Ola Landgren, MD, Memorial Sloan Kettering Cancer Center
Daniel Auclair, PhD, MMRF

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter